Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intrapartum Sildenafil Citrate to Prevent Non Reassuring Foetal Status Among Parturients Delivering at LAUTECH Teaching Hospital, Ogbomoso, a Randomised Controlled Trial

NCT05558176 is registered in ClinicalTrials.gov with Ladoke Akintola University of Technology Teaching Hospital, Ogbomoso as lead sponsor.

NCT NCT05558176
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05558176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intrapartum Sildenafil Citrate to Prevent Non Reassuring Foetal Status Among Parturients Delivering at LAUTECH Teaching Hospital, Ogbomoso, a Randomised Controlled Trial
Lead sponsor
Ladoke Akintola University of Technology Teaching Hospital, Ogbomoso
Phase
Phase 4
Overall status
Unknown status
Start date
April 8, 2022
Completion date
October 31, 2022
Enrollment
176 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

foetal hypoxia